The Efficacy of Gabapentin+Dexamethasone for Postoperative Analgesia Following Septoplasty: A Prospective Randomized Placebo-Controlled Trial
dc.contributor.author | Kandemir, Süheyla | |
dc.contributor.author | Pamuk, A.Erim | |
dc.contributor.author | Özel, Gökçe | |
dc.contributor.author | Gençay, Işın | |
dc.contributor.author | Kılıç, Rahmi | |
dc.date.accessioned | 2025-01-21T16:28:55Z | |
dc.date.available | 2025-01-21T16:28:55Z | |
dc.date.issued | 2023 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | Aims: This study aimed to compare the efficacy of gabapentin, dexamethasone, and gabapentin + dexamethasone for pain control after septoplasty. Materials and Methods: This prospective randomized trial included 120 patients that underwent septoplasty and were randomly divided into 4 groups: group G (preoperative gabapentin 600 mg p.o.); group D (intraoperative dexamethasone 8 mg i.v.); group GD (preoperative gabapentin 600 mg p.o. + intraoperative dexamethasone 8 mg i.v.); group C (placebo control). Results: The median VAS score was significantly lower in groups G and GD at 1, 2, 4, 6, 12, and 24 hours postsurgery than in group C (P <.008 for all). The median VAS score was significantly lower in group D than in group C at 1, 2, and 4 hours postsurgery (P <.008 for all). There weren’t any significant differences in the VAS score between groups D, G, and GD at any time point. Groups G, D, and GD had a significantly lower frequency of rescue analgesic use than group C; however, there were no differences between groups G, GD, and C (P <.001 and P =.108, respectively). Conclusion: Gabapentin, dexamethasone, and gabapentin + dexamethasone are equally more effective analgesics during the first 4 hours postsurgery than placebo. The addition of dexamethasone to gabapentin does not provide extra analgesia. Both gabapentin and gabapentin + dexamethasone have a more prolonged analgesic effect than dexamethasone alone. © The Author(s) 2022. | |
dc.identifier.doi | 10.1177/00034894221089162 | |
dc.identifier.endpage | 309 | |
dc.identifier.issn | 0003-4894 | |
dc.identifier.issue | 3 | |
dc.identifier.pmid | 35450447 | |
dc.identifier.scopus | 2-s2.0-85129727531 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 304 | |
dc.identifier.uri | https://doi.org/10.1177/00034894221089162 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/23635 | |
dc.identifier.volume | 132 | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | SAGE Publications Inc. | |
dc.relation.ispartof | Annals of Otology, Rhinology and Laryngology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_20241229 | |
dc.subject | analgesia; dexamethasone; gabapentin; postoperative pain; septoplasty | |
dc.title | The Efficacy of Gabapentin+Dexamethasone for Postoperative Analgesia Following Septoplasty: A Prospective Randomized Placebo-Controlled Trial | |
dc.type | Article |